OpenSAFELY Vaccine Coverage Report
AstraZeneca / Priority Group 5
Data from combined, up to 2021-03-07.
| Vaccinated at 2021-03-07 (%) | Vaccinated at 2021-03-07 (n) | Population | Vaccinated at 2021-02-28 (%) | Vaccinated in past week (%) | ||
|---|---|---|---|---|---|---|
| Overall | - | 56.6% | 1,396,822 | 2,469,026 | 53.3% | 3.3% |
| Sex | Female | 56.6% | 712,593 | 1,259,475 | 53.3% | 3.3% |
| Male | 56.6% | 684,229 | 1,209,551 | 53.3% | 3.3% | |
| Ethnicity | White - British | 59.5% | 859,208 | 1,445,248 | 56.3% | 3.2% |
| White - Irish | 54.2% | 8,435 | 15,568 | 51.6% | 2.6% | |
| White - Any other White background | 41.1% | 32,494 | 79,128 | 38.5% | 2.5% | |
| Mixed - White and Black Caribbean | 37.6% | 1,190 | 3,164 | 33.8% | 3.8% | |
| Mixed - White and Black African | 37.9% | 973 | 2,569 | 34.6% | 3.3% | |
| Mixed - White and Asian | 50.3% | 1,281 | 2,548 | 47.5% | 2.7% | |
| Mixed - Any other mixed background | 43.7% | 2,149 | 4,921 | 40.5% | 3.1% | |
| Asian or Asian British - Indian | 51.2% | 25,725 | 50,218 | 49.2% | 2.0% | |
| Asian or Asian British - Pakistani | 42.3% | 10,570 | 24,983 | 38.9% | 3.4% | |
| Asian or Asian British - Bangladeshi | 48.5% | 2,996 | 6,174 | 44.2% | 4.3% | |
| Asian or Asian British - Any other Asian background | 46.4% | 10,388 | 22,407 | 43.8% | 2.6% | |
| Black or Black British - Caribbean | 34.3% | 5,117 | 14,924 | 30.8% | 3.5% | |
| Black or Black British - African | 34.8% | 5,299 | 15,211 | 31.1% | 3.8% | |
| Black or Black British - Any other Black background | 38.2% | 1,386 | 3,633 | 34.3% | 3.9% | |
| Other ethnic groups - Chinese | 45.0% | 4,221 | 9,380 | 41.6% | 3.4% | |
| Other ethnic groups - Any other ethnic group | 40.1% | 5,306 | 13,216 | 37.3% | 2.9% | |
| Patients with any other ethnicity code | 56.3% | 184,002 | 326,662 | 52.8% | 3.6% | |
| Ethnicity not stated | 54.4% | 8,225 | 15,120 | 50.9% | 3.5% | |
| Ethnicity not recorded | 55.0% | 227,759 | 413,847 | 51.3% | 3.8% | |
| Ethnicity (broad categories) | White | 58.5% | 900,151 | 1,539,958 | 55.3% | 3.2% |
| Mixed | 42.4% | 5,600 | 13,209 | 39.4% | 3.0% | |
| South Asian | 47.9% | 49,700 | 103,796 | 45.2% | 2.6% | |
| Black | 35.0% | 11,816 | 33,782 | 31.3% | 3.7% | |
| Other | 42.2% | 9,534 | 22,610 | 39.0% | 3.1% | |
| Unknown | 55.6% | 419,993 | 755,650 | 51.9% | 3.7% | |
| Index of Multiple Deprivation | 1 (most deprived) | 53.8% | 414,225 | 769,692 | 50.5% | 3.4% |
| 2 | 53.6% | 190,463 | 355,047 | 49.7% | 4.0% | |
| 3 | 56.8% | 241,521 | 425,523 | 53.2% | 3.5% | |
| 4 | 59.1% | 264,320 | 446,950 | 56.1% | 3.1% | |
| 5 (least deprived) | 61.0% | 274,491 | 450,282 | 58.4% | 2.6% | |
| Unknown | 54.7% | 11,781 | 21,518 | 49.7% | 5.0% | |
| Clinical Risk Groups | Patients in Any Clinical Risk Group | 57.1% | 515,473 | 902,923 | 53.8% | 3.3% |
| Patients with Immunosuppression | 58.1% | 21,819 | 37,541 | 55.1% | 3.0% | |
| Patients with CKD | 57.7% | 66,913 | 115,997 | 54.5% | 3.2% | |
| Patients who have Chronic Respiratory Disease | 57.0% | 54,950 | 96,425 | 53.6% | 3.4% | |
| Patients with Diabetes | 56.4% | 182,798 | 324,366 | 53.1% | 3.3% | |
| Patients with Chronic Liver disease | 56.1% | 41,153 | 73,311 | 52.9% | 3.2% | |
| Patients with CNS Disease (including Stroke/TIA) | 57.8% | 77,903 | 134,673 | 54.1% | 3.7% | |
| Patients with Chronic heart disease | 57.8% | 216,055 | 374,017 | 54.5% | 3.3% | |
| Patients with Asplenia or Dysfunction of the Spleen | 59.7% | 8,435 | 14,140 | 56.5% | 3.1% | |
| Patients with Wider Learning Disability | 51.9% | 3,010 | 5,796 | 44.3% | 7.6% | |
| Patients with Severe Mental Health | 50.1% | 11,865 | 23,688 | 45.4% | 4.7% | |
| Other Groups | Patients with Morbid Obesity | 56.4% | 43,897 | 77,875 | 52.7% | 3.7% |
| Patients who are pregnant | 58.3% | 147 | 252 | 55.6% | 2.8% |